메뉴 건너뛰기




Volumn 893-894, Issue , 2012, Pages 92-100

Corrigendum to "Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine" [J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 893-894 (2012) 92-100] DOI: 10.1016/j.jchromb.2012.02.039.;Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine

Author keywords

Alkylating agent; Bendamustine; LC MS MS; Metabolites; Stability

Indexed keywords

ASSAYS; BIOMOLECULES; BODY FLUIDS; CONVERGENCE OF NUMERICAL METHODS; DISEASES; ELECTROSPRAY IONIZATION; HYDROLYSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; PATIENT MONITORING; PATIENT TREATMENT; PHASE SEPARATION; PLASMA (HUMAN); SOLUTIONS;

EID: 84859443885     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2016.03.016     Document Type: Erratum
Times cited : (34)

References (9)
  • 2
    • 84859442285 scopus 로고    scopus 로고
    • United States National Institutes of Health (accessed 1.11.11).
    • United States National Institutes of Health, 2011, (accessed 1.11.11). http://clinicaltrials.gov/ct2/results%3Fterm=bendamustine%26no_unk=Y.
    • (2011)
  • 6
    • 84859438171 scopus 로고    scopus 로고
    • US FDA, (accessed 9.1.12).
    • US FDA, 2001, (accessed 9.1.12). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf.
    • (2001)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.